Abstract
Linoleic acid (18:2 ω-6, LA) has been known since 1956 to be one dietary component that lowers serum total and LDL-cholesterol, hence risk of CHD. It has taken time before becoming clear that LA itself, in diet or in plasma lipids is inversely related to CHD incidence. Evidence has accumulated gradually (Table 25.1), culminating in results from the large US Nurses Cohort (1997). LA also appears to reduce the tendency to thrombosis and risk of dangerous cardiac arrhythmias.
LA is not a precursor of arachidonic acid (potentially thrombogenic) at ordinary intake levels and fears that it interferes with conversion of linolenic to EPA have been exaggerated. Years: build up to 1997.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsAuthor information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media B.V.
About this chapter
Cite this chapter
Truswell, A.S. (2010). Linoleic Acid is Protective. In: Cholesterol and Beyond. Springer, Dordrecht. https://doi.org/10.1007/978-90-481-8875-8_25
Download citation
DOI: https://doi.org/10.1007/978-90-481-8875-8_25
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-90-481-8874-1
Online ISBN: 978-90-481-8875-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)